Who are we? - BlueReg Group

Our Purpose

What is our mission?

We provide strategy and tailored solutions to our clients, from start-up to large life sciences companies, to support their ability to develop and offer healthcare products to patients.

We encourage motivation and development of our people through opportunities to learn in a supportive and positive environment.

For what world?

BlueReg aims to contribute to a world where patients have better access to a variety of safe, effective healthcare products, and innovative treatments.

We created our philosophy “Be, BlueReg” by involving everyone in the company. Hence, our values, mission statement, and what we stand for were developed and sanctioned by every single member of our company, such is the collaborative spirit within us.

Our “raison d’etre”, or reason for being, is embedded in our everyday life and we run our business with :

Integrity: in a transparent and fair manner with our clients and employees, respecting confidentiality and establishing relationships of trust and loyalty with our clients.
Team Spirit: transversally, in a spirit of solidarity and respecting everyone’s point of view and by taking advantage of our diversity to enrich the team’s experience and expertise.
Commitment: with clear and shared objectives, with passion, proactivity, results driven mindset and a strong customer focus to build trust and loyalty and to ensure customer satisfaction
Agility: proactively to ensure the success of our clients, by being flexible and positive to change and ready to acquire new skills and take on new challenges.

Our Story

2011: Creation of BlueReg by our CEO, Corinne Schmitz, Pharm.D., with the objective to support life science companies in the development, registration and marketing of healthcare products in France, Europe and worldwide. Our first office is opened in Sophia-Antipolis.

2013: Opening of the second French office in Paris with the aim of getting closer to some of our clients.

2015: Creation of a subsidiary in the United Kingdom and opening of an office near London (High Wycombe) accelerating BlueReg’s ability to support European clients.

2015: Creation of a new subsidiary in France, PharmaBlue, to complement BlueReg’s offerered services. PharmaBlue is a “Laboratoire Exploitant” (authorized by the ANSM) enabling some of BlueReg clients to market early access medicines under ATU.

2017: Geographic expansion in the United States and creation of a subsidiary in New York. This subsidiary provides support to a growing customer base in North America and to many European customers seeking to register products in the United States.

2018: European geographic expansion in Amsterdam and opening of a Dutch office near the European Medicines Agency (EMA).

2019: BlueReg continues its expansion in the United States by opening its second North American office in Boston, Massachusetts. BlueReg supports more and more clients in this region.

Today: BlueReg has more than 70 employees. Our consultants are highly qualified with practical experience in the pharmaceutical industry. BlueReg supports more than 125 clients, based in France, in Europe and in the United States, to register or market products worldwide.

Paris

9 avenue Percier
75008 Paris
France

+33 (0)1 82 73 10 00

Sophia Antipolis

1800 route des Crêtes
Les 2 Arcs – Bât A
06560 Valbonne
France

+33 (0)4 22 00 01 00

London

Buckingham Court
Kingsmead Business Park
Frederick Place
High Wycombe
Bucks HP11 1JU
United Kingdom

+44 (0) 3333 112131

Amsterdam

Gustav Mahlerplein 2
1082 MA
Amsterdam
Netherlands

+31 (0) 20-799-7487

Boston

Cambridge Innovation Center
One Broadway
Cambridge
MA 02142
USA

+1 (833) BLUEREG

New York

62 William Street
8th Floor
New York
NY, 10005
USA